The number of people with susceptibility test result for rifampicin in Mexico
Mexico: The number of people with susceptibility test result for rifampicin was 35.3 in 2021. ◆ Volatile
Latest (2021)
35.3
Change on year
up 48.9%
World rank
128th
of 146 countries
All-time high
35.3
in 2021
All-time low
0.3771
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Mexico, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Mexico recorded 35.3 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
That represents a change of up 48.9% on the previous year and up 9,261.3% over five years.
That places Mexico 128th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Mexico, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0.3771 | — |
| 2018 | 0.5523 | +46.5% |
| 2019 | 2.89 | +423.8% |
| 2020 | 23.72 | +719.8% |
| 2021 | 35.3 | +48.9% |
Mexico compared with similar countries
- Mexico's 35.3 is below the median for upper middle income countries, which is 92.7, 38% of the median. (45 countries reporting)
- Mexico's 35.3 is below the median for Latin America & Caribbean, which is 59.38, 59% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.27 | 0.3771 | 2.89 | 3 |
| 2020s | 29.51 | 23.72 | 35.3 | 2 |
Countries ranked near Mexico
More health data for Mexico
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,312 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,760 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.9607 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0377 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.9678 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Mexico?
- The number of people with susceptibility test result for rifampicin in Mexico was 35.3 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Mexico?
- The highest recorded value was 35.3 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Mexico?
- The lowest recorded value was 0.3771 in 2017.
- How does Mexico rank for the number of people with susceptibility test result for rifampicin?
- Mexico ranks 128th out of 146 countries with data for 2021.
- Where does this Mexico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).